Centre for Research on Ageing, Health and Wellbeing, The Australian National University, Canberra, Australia.
Addiction. 2012 Nov;107(11):1998-2008. doi: 10.1111/j.1360-0443.2012.03933.x. Epub 2012 Jul 12.
To evaluate the impact of community-based drug treatment on methamphetamine use using inverse probability of treatment-weighted (IPTW) estimators to derive treatment effects.
A longitudinal prospective cohort study with follow-ups at 3 months, 1 year and 3 years. Treatment effects were derived by comparing groups at follow-up. IPTW estimators were used to adjust for pre-treatment differences between groups.
Sydney and Brisbane, Australia.
Participants were methamphetamine users entering community-based detoxification (n = 112) or residential rehabilitation (n = 248) services and a quasi-control group of methamphetamine users (n = 101) recruited from the community.
Frequency of methamphetamine use between interviews (no use, less than weekly, 1-2 days per week, 3+ days per week), continuous abstinence from methamphetamine use, past month methamphetamine use and methamphetamine dependence.
Detoxification did not reduce methamphetamine use at any follow-up relative to the quasi-control group. Relative to quasi-control and detoxification groups combined, residential rehabilitation produced large reductions in the frequency of methamphetamine use at 3 months [odds ratio (OR) = 0.23, 95% confidence interval (CI) 0.15-0.36, P < 0.001), with a marked attenuation of this effect at 1 year (OR 0.62, 95% CI 0.40-0.97, P = 0.038) and 3 years (OR = 0.71, 95% CI 0.42-1.19, P = 0.189). The greatest impact was for abstinence: for every 100 residential rehabilitation clients there was a gain of 33 being continuously abstinent at 3 months, with this falling to 14 at 1 year and 6 at 3 years.
Community-based residential rehabilitation may produce a time-limited decrease in methamphetamine use, while detoxification alone does not appear to do so.
使用逆概率治疗加权(Inverse Probability of Treatment Weighted,IPTW)估计器评估基于社区的药物治疗对甲基苯丙胺使用的影响,以得出治疗效果。
一项具有 3 个月、1 年和 3 年随访的纵向前瞻性队列研究。通过比较随访时的组间差异来得出治疗效果。使用 IPTW 估计器来调整组间治疗前的差异。
澳大利亚悉尼和布里斯班。
进入基于社区的戒毒(n=112)或住院康复(n=248)服务的甲基苯丙胺使用者和从社区招募的准对照组甲基苯丙胺使用者(n=101)。
访谈期间甲基苯丙胺使用的频率(不使用、每周不到一次、每周 1-2 天、每周 3 天以上)、连续戒除甲基苯丙胺、过去一个月使用甲基苯丙胺和甲基苯丙胺依赖。
与准对照组相比,戒毒治疗在任何随访时都没有减少甲基苯丙胺的使用。与准对照组和戒毒组联合相比,住院康复治疗在 3 个月时显著降低了甲基苯丙胺的使用频率[比值比(OR)=0.23,95%置信区间(CI)0.15-0.36,P<0.001],在 1 年(OR 0.62,95% CI 0.40-0.97,P=0.038)和 3 年(OR=0.71,95% CI 0.42-1.19,P=0.189)时效果明显减弱。最大的影响是在禁欲方面:每 100 名住院康复患者中,有 33 人在 3 个月时持续禁欲,而在 1 年时下降到 14 人,在 3 年时下降到 6 人。
基于社区的住院康复治疗可能会在短期内减少甲基苯丙胺的使用,而单独戒毒治疗似乎不会产生这种效果。